General practitioner–led vs surgeon-led colon cancer survivorship care: a randomized clinical trial
JNCI Cancer Spectrum · 30.04.2025 · 9 (3)
DOI: 10.1093/jncics/pkaf052 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 01.06.2025. Verfasst von Julien A M Vos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Colonic Neoplasms, Cancer Survivors, General Practitioners. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: KWF Kankerbestrijding, Stichting Alpe d'HuZes, Stichting Alpe d’HuZes.
Abstract (Originalsprache)
The randomized controlled I CARE (Improving Care After colon canceR treatment in the Netherlands) trial evaluated the impact of general practitioner–led vs surgeon-led survivorship care on quality of life (QoL) in colorectal cancer survivors, alongside the effect of the eHealth application Oncokompas. The trial was conducted in 8 hospitals and 225 general practices across the Netherlands, including 303 patients who underwent surgery for stage I-III colon cancer or rectosigmoid carcinoma. Patients were randomly assigned into 4 groups: surgeon-led care, surgeon-led care with Oncokompas, general practitioner–led care, and general practitioner–led care with Oncokompas. QoL was assessed at multiple time points over 60 months. At 60 months, no clinically relevant differences in QoL were found between general practitioner–led and surgeon-led care (difference in summary score = −0.5, 95% CI = −1.6 to 0.5) or with Oncokompas (difference = 0.8, 95% CI = 0.0 to 1.6). In conclusion, neither general practitioner involvement nor access to Oncokompas led to clinically relevant improvements in long-term QoL. Survivorship care can be tailored to preferences. Netherlands Trial Register; NTR4860.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Practice, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
- Department of Otolaryngology-Head and Neck Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Clinical Neuro- and Developmental Psychology, Section Clinical Psychology, Amsterdam Public Health, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Julien A M Vos, Laura A M Duineveld, Wim B Busschers, Henk C P M van Weert, Kristel M van Asselt
Förderung
- KWF Kankerbestrijding
- Stichting Alpe d'HuZes
- Stichting Alpe d’HuZes
Zitieren
APA
Vos, J. A. M., Duineveld, L. A. M., Wieldraaijer, T., Wind, J., Busschers, W. B., Sert, E., Verdonck-de Leeuw, I. M., van Weert, H. C. P. M., & van Asselt, K. M. (2025). General practitioner–led vs surgeon-led colon cancer survivorship care: a randomized clinical trial. JNCI Cancer Spectrum, 9(3). https://doi.org/10.1093/jncics/pkaf052
Vancouver
Vos JAM, Duineveld LAM, Wieldraaijer T, Wind J, Busschers WB, Sert E, et al. General practitioner–led vs surgeon-led colon cancer survivorship care: a randomized clinical trial. JNCI Cancer Spectrum. 2025;9(3). doi:10.1093/jncics/pkaf052
BibTeX
@article{Vos2025,
author = {Vos, Julien A M and Duineveld, Laura A M and Wieldraaijer, Thijs and Wind, Jan and Busschers, Wim B and Sert, Edanur and Verdonck-de Leeuw, Irma M and van Weert, Henk C P M and van Asselt, Kristel M},
title = {General practitioner–led vs surgeon-led colon cancer survivorship care: a randomized clinical trial},
journal = {JNCI Cancer Spectrum},
year = {2025},
volume = {9},
number = {3},
doi = {10.1093/jncics/pkaf052}
}
EUVIMED